Closed · RFA-NR-10-001 · CFDA 93.361 · Discretionary
Chronic Co-Morbid Conditions in HIV+ U.S. Adults on Highly-Effective Anti-Retroviral Therapy (R01)
Federal grant opportunity posted by National Institutes of Health, cataloged on Grants.gov.
- up to $500K
- Award range
- Closed
- Status
- May 5, 2010
- Close date
- -
- Expected awards
The verdict
Chronic Co-Morbid Conditions in HIV+ U.S. Adults on Highly-Effective Anti-Retroviral Therapy (R01) is a closed discretionary listing from National Institutes of Health that offered Up to $500,000. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 12,419 other opportunities from National Institutes of Health.
- up to $500K
- award range
- Closed
- application status
- 93.361
- CFDA program
- 12,419
- other opportunities from National Institutes of Health
Archived opportunity record
Chronic Co-Morbid Conditions in HIV+ U.S. Adu… is closed (last close May 5, 2010). The parent program page for CFDA 93.361 is the reliable place to catch re-announcements. National Institutes of Health still indexes 12,419 other opportunities here.
According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.
Deadline tracker
Application window closed
Closed May 5, 2010
Est. Total Funding
$1,875,000
Instrument
Grant
Description
Purpose. This FOA issued by National Institute of Nursing Research, National Institutes of Health, solicits Research Project Grant (R01) applications from institutions/organizations proposing mechanistic projects or interventions designed to understand or intervene in chronic co-morbid conditions common to HIV+ adults living in the U.S. who are treated with anti-retroviral therapy. These conditions may be a result of anti-retroviral therapy or the HIV disease process. These same kinds of conditions may also be common in older non-infected adults, but more information is needed on the natural history, including both biological and behavioral manifestations, and appropriate intervention when HIV+ adults are affected by conditions, such as cachexia, diabetes, kidney disease, neurological changes, cardiovascular disease or cancer. Since the advent of the protease inhibitors in 1996-1997, anti-retroviral treatment options have been evolving, including the customized combination ART. It is important to evaluate this progress and identify new opportunities for research associated with the use of anti-retroviral therapies and the association of co-morbidities of HIV+ individuals as they live through middle and old age. Research exploring these issues utilizing interdisciplinary and multidisciplinary research teams is strongly encouraged, as are research teams including underrepresented, minority, disabled, or women investigators. Mechanism of Support. This FOA will utilize the R01 grant mechanism and runs in parallel with a FOA of identical scientific scope, RFA-NR-10-002, that encourages applications under the R21 mechanism.
Wide-open applicant board · 15 Grants.gov doors
Chronic Co-Morbid Conditions in HIV+ U.S. Adu… prints 15 distinct Grants.gov eligibility doors (State governments; County governments; City or township governments; Special district governments; +11 more). Filter fit before reading award size as demand — most applicant classes appear on the row. The extract does not mark applicant cost-sharing as required. Instrument: Grant. Funding-activity codes span Education · Health (ED;HL). This eligibility-code string dominates the National Institutes of Health book (9,741 peers, 78% of 12,420).
- Code 00
- State governments
- Code 01
- County governments
- Code 02
- City or township governments
- Code 04
- Special district governments
- Code 05
- Independent school districts
- Code 06
- Public / state-controlled institutions of higher education
- Code 07
- Federally recognized tribal governments
- Code 08
- Public / Indian housing authorities
- Code 11
- Native American tribal organizations (other than Federally recognized tribal governments)
- Code 12
- Nonprofits with 501(c)(3) status (other than IHEs)
- Code 13
- Nonprofits without 501(c)(3) status (other than IHEs)
- Code 20
- Private institutions of higher education
- Code 22
- For-profit organizations other than small businesses
- Code 23
- Small businesses
- Code 25
- Others (see official listing text)
Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Parent Grant Program
Nursing Research
National Institutes of Health
Agency Contact
NIH OER Webmaster FBOWebmaster@OD.NIH.GOV
More from National Institutes of Health
Validation Center for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U54 Clinical Trials Not Allowed)
Logistics Center for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U24 Clinical Trials Not Allowed)
Development and Testing of a Multi-use Frameworks Playbook for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U01 Clinical Trial Not Allowed)
PRIMED-AI: Data-to-Model Academic-Industrial Partnerships (D2M-AIP) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (UG3/UH3 Clinical Trial Optional)
Model-to-Clinic (M2C) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (UG3/UH3, Clinical Trial Optional)
What to do next
Chronic Co-Morbid Conditions in HIV+ U.S. Adu… is closed; use the parent program and agency catalog for the next funding cycle.
- Parent CFDA 93.361 may publish future NOFOs under the same assistance listing. Open program
- Nursing Research indexes 88 Grants.gov listings in this extract. Program profile
- National Institutes of Health lists 12,419 other indexed opportunities on PlainGrants. Agency catalog
Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |